; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal
; Department of Dermatology, Centro Hospitalar do Porto, PortugalInstituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal
APA 6th Edition Sales, R. i Torres, T. (2014). Psoriasis and metabolic syndrome. Acta Dermatovenerologica Croatica, 22 (3), 169-169. Preuzeto s https://hrcak.srce.hr/126588
MLA 8th Edition Sales, Rita i Tiago Torres. "Psoriasis and metabolic syndrome." Acta Dermatovenerologica Croatica, vol. 22, br. 3, 2014, str. 169-169. https://hrcak.srce.hr/126588. Citirano 27.10.2021.
Chicago 17th Edition Sales, Rita i Tiago Torres. "Psoriasis and metabolic syndrome." Acta Dermatovenerologica Croatica 22, br. 3 (2014): 169-169. https://hrcak.srce.hr/126588
Harvard Sales, R., i Torres, T. (2014). 'Psoriasis and metabolic syndrome', Acta Dermatovenerologica Croatica, 22(3), str. 169-169. Preuzeto s: https://hrcak.srce.hr/126588 (Datum pristupa: 27.10.2021.)
Vancouver Sales R, Torres T. Psoriasis and metabolic syndrome. Acta Dermatovenerol Croat. [Internet]. 2014 [pristupljeno 27.10.2021.];22(3):169-169. Dostupno na: https://hrcak.srce.hr/126588
IEEE R. Sales i T. Torres, "Psoriasis and metabolic syndrome", Acta Dermatovenerologica Croatica, vol.22, br. 3, str. 169-169, 2014. [Online]. Dostupno na: https://hrcak.srce.hr/126588. [Citirano: 27.10.2021.]
Psoriasis is a chronic, systemic inflammatory disease associated with several cardiometabolic comorbidities, such as obesity, insulin resistance, dyslipidemia, and hypertension, and with clinically significant increased risk of cardiovascular disease and cardiovascular mortality. These comorbidities are components of the metabolic syndrome. Multiple epidemiologic studies have revealed a high prevalence of metabolic syndrome in patients with psoriasis compared with other skin diseases. Genetic susceptibility and overlapping inflammatory pathways may be potential biologic links underlying this association. Understanding the interrelationship between these conditions is important for the management of psoriasis and its associated comorbidities. This review will focus on the range of these comorbidities, with emphasis on the metabolic syndrome, aiming to encourage physicians to screen patients with psoriasis for cardiometabolic disorders and risk factors.